Cita APA

Haslett, K., Koh, P., Hudson, A., Ryder, W., Falk, S., Mullan, D., . . . Faivre-Finn, C. (2021). Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer. Clin Transl Radiat Oncol.

Chicago Style Citation

Haslett, K., et al. "Phase I Trial of the MEK Inhibitor Selumetinib in Combination With Thoracic Radiotherapy in Non-small Cell Lung Cancer." Clin Transl Radiat Oncol 2021.

Cita MLA

Haslett, K., et al. "Phase I Trial of the MEK Inhibitor Selumetinib in Combination With Thoracic Radiotherapy in Non-small Cell Lung Cancer." Clin Transl Radiat Oncol 2021.